OpenAI Misses Revenue and User Targets — AI Stocks Tumble
The Wall Street Journal dropped a bombshell Monday: OpenAI — the $852 billion poster child of the AI boom — has missed both user growth and revenue ta...
The Wall Street Journal dropped a bombshell Monday: OpenAI — the $852 billion poster child of the AI boom — has missed both user growth and revenue ta...
Every day, thousands of developers have brilliant SaaS ideas that never see the light of day. They get stuck in planning paralysis, over-engineer solu...
In one of the largest Series A rounds in robotics history, Mind Robotics—a spin-out from electric vehicle maker Rivian—has secured a staggering $500 m...
Runway, the $5.3 billion AI video generation startup that brought us tools used in Hollywood films and viral marketing campaigns, just dropped a bombs...
OpenAI just closed a $122 billion funding round at an $852 billion valuation—making it the most valuable private company in history and signaling that...
DeepSeek went out for about $7 billion and investors came back with at least $12 billion, in a Tencent- and CATL-led round ahead of a planned 2027 IPO.
🔥 Gigabyte Just Dropped a $400 WOLED Gaming Monitor and It Changes Everything...
The AI chip company Cerebras Systems — the most prominent challenger to Nvidia's GPU empire — hit the Nasdaq on Thursday under the ticker CBRS and...
> In 2025, startups discovered AI. In 2026, the winners figured out which tools to use and when. Here's the stack the smartest founders are runni...
Bending Spoons is buying Airtable for $1.285 billion in all cash — about 89% below the productivity startup's $11.7B pandemic-era peak, and its first deal since going public.
The FDA just approved FAYUVI, the first-ever treatment for Sanfilippo syndrome type A: a one-time gene therapy from Ultragenyx priced at $3.95 million per patient.
Adicet's off-the-shelf CAR-T put 54% of a small lupus trial into remission on a single dose. Then the stock dropped 22%.
Precision Neuroscience closed an oversubscribed $250M Series D at a ~$1B valuation, betting its surface brain implant beats drilling into tissue.